Membrane anchoring of epstein-barr virus gp42 inhibits fusion with B cells even with increased flexibility allowed by engineered spacers

mBio

Volumn 6, Issue 1, 2015, Pages

  Rowe, Cynthia L ^a   Chen, Jia ^a   Jardetzky, Theodore S ^b   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIN; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN; MEMBRANE PROTEIN; PROTEIN GH GL; PROTEIN GP42; UNCLASSIFIED DRUG; VIRUS PROTEIN; CHAPERONE; GLYCOPROTEIN; GLYCOPROTEIN H, HERPESVIRUS 4; GLYCOPROTEIN L, HUMAN HERPESVIRUS 4; VIRAL PROTEIN; VIRUS ENVELOPE PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL FUSION; CHINESE HAMSTER; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; CELL MEMBRANE; CHEMISTRY; EPSTEIN BARR VIRUS INFECTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; VIROLOGY; VIRUS ENTRY;

HUMAN HERPESVIRUS 4;

B-LYMPHOCYTES; CELL FUSION; CELL MEMBRANE; EPSTEIN-BARR VIRUS INFECTIONS; GLYCOPROTEINS; HERPESVIRUS 4, HUMAN; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR CHAPERONES; PROTEIN STRUCTURE, TERTIARY; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRUS INTERNALIZATION;

EID: 84924103832     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02285-14     Document Type: Article

References (29)

1. Longnecker R, Kieff E, Cohen JI. 2013. Epstein-Barr virus, p 1898-1959. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R. 2011. Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol 9: 369-381. http://dx. doi. org/10. 1038/nrmicro2548.
3. Haan KM, Kwok WW, Longnecker R, Speck P. 2000. Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor. J Virol 74: 2451-2454. http://dx. doi. org/10. 1128/JVI. 74. 5. 2451-2454. 2000.
4. Li Q, Spriggs MK, Kovats S, Turk SM, Comeau MR, Nepom B, Hutt-Fletcher LM. 1997. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J Virol 71: 4657-4662.
5. Borza CM, Hutt-Fletcher LM. 2002. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8: 594-599. http://dx. doi. org/10. 1038/nm0602-594.
6. Chesnokova LS, Hutt-Fletcher LM. 2011. Fusion of Epstein-Barr virus with epithelial cells can be triggered by (v)5 in addition to (v)6 and (v)8, and integrin binding triggers a conformational change in glycoproteins gHgL. J Virol 85: 13214-13223. http://dx. doi. org/10. 1128/JVI. 05580-11.
7. Chesnokova LS, Nishimura SL, Hutt-Fletcher LM. 2009. Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins (v)6 or (v)8. Proc Natl Acad Sci U S A 106: 20464-20469. http://dx. doi. org/10. 1073/pnas. 0907508106.
8. Li Q, Turk SM, Hutt-Fletcher LM. 1995. The Epstein-Barr virus (EBV) gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J Virol 69: 3987-3994.
9. Ressing ME, van Leeuwen D, Verreck FA, Keating S, Gomez R, Franken KL, Ottenhoff TH, Spriggs M, Schumacher TN, Hutt-Fletcher LM, Rowe M, Wiertz EJ. 2005. Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion. J Virol 79: 841-852. http://dx. doi. org/10. 1128/JVI. 79. 2. 841-852. 2005.
10. Sorem J, Jardetzky TS, Longnecker R. 2009. Cleavage and secretion of Epstein-Barr virus glycoprotein 42 promote membrane fusion with B lymphocytes. J Virol 83: 6664-6672. http://dx. doi. org/10. 1128/JVI. 00195-09.
11. Kirschner AN, Omerovic J, Popov B, Longnecker R, Jardetzky TS. 2006. Soluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1: 1: 1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion. J Virol 80: 9444-9454. http://dx. doi. org/10. 1128/JVI. 00572-06.
12. Wang X, Kenyon WJ, Li Q, Müllberg J, Hutt-Fletcher LM. 1998. Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J Virol 72: 5552-5558.
13. Liu F, Marquardt G, Kirschner AN, Longnecker R, Jardetzky TS. 2010. Mapping the N-terminal residues of Epstein-Barr virus gp42 that bind gH/gL by using fluorescence polarization and cell-based fusion assays. J Virol 84: 10375-10385. http://dx. doi. org/10. 1128/JVI. 00381-10.
14. Chen J, Jardetzky TS, Longnecker R. 2013. The large groove found in the gH/gL structure is an important functional domain for Epstein-Barr virus fusion. J Virol 87: 3620-3627. http://dx. doi. org/10. 1128/JVI. 03245-12.
15. Chen J, Rowe CL, Jardetzky TS, Longnecker R. 2012. The KGD motif of Epstein-Barr virus gH/gL is bifunctional, orchestrating infection of B cells and epithelial cells. mBio 3(1): e00290-11. http://dx. doi. org/10. 1128/mBio. 00290-11.
16. Mullen MM, Haan KM, Longnecker R, Jardetzky TS. 2002. Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. Mol Cell 9: 375-385. http://dx. doi. org/10. 1016/S1097-2765(02)00465-3.
17. Matsuura H, Kirschner AN, Longnecker R, Jardetzky TS. 2010. Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H/glycoprotein L (gH/gL) complex. Proc Nat Acad Sci U S A 107: 22641-22646.
18. Kirschner AN, Lowrey AS, Longnecker R, Jardetzky TS. 2007. Bindingsite interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion. J Virol 81: 9216-9229. http://dx. doi. org/10. 1128/JVI. 00575-07.
19. Sathiyamoorthy K, Jiang J, Hu YX, Rowe CL, Mohl BS, Chen J, Jiang W, Mellins ED, Longnecker R, Zhou ZH, Jardetzky TS. 2014. Assembly and architecture of the EBV B cell entry triggering complex. PLoS Pathog 10: e1004309. http://dx. doi. org/10. 1371/journal. ppat. 1004309.
20. Politou AS, Gautel M, Pfuhl M, Labeit S, Pastore A. 1994. Immunoglobulin-type domains of titin: same fold, different stability? Biochemistry 33: 4730-4737. http://dx. doi. org/10. 1021/bi00181a604.
21. Improta S, Politou AS, Pastore A. 1996. Immunoglobulin-like modules from titin I-band: extensible components of muscle elasticity. Structure 4: 323-337. http://dx. doi. org/10. 1016/S0969-2126(96)00036-6.
22. Inobe T, Fishbain S, Prakash S, Matouschek A. 2011. Defining the geometry of the two-component proteasome degron. Nat Chem Biol 7: 161-167. http://dx. doi. org/10. 1038/nchembio. 521.
23. von Castelmur E, Marino M, Svergun DI, Kreplak L, Ucurum-Fotiadis Z, Konarev PV, Urzhumtsev A, Labeit D, Labeit S, Mayans O. 2008. A regular pattern of Ig super-motifs defines segmental flexibility as the elastic mechanism of the titin chain. Proc Natl Acad SciUSA105: 1186-1191. http://dx. doi. org/10. 1073/pnas. 0707163105.
24. Rowe CL, Matsuura H, Jardetzky TS, Longnecker R. 2011. Investigation of the function of the putative self-association site of Epstein-Barr virus (EBV) glycoprotein 42 (gp42). Virology 415: 122-131. http://dx. doi. org/10. 1016/j. virol. 2011. 04. 003.
25. Rowe CL, Connolly SA, Chen J, Jardetzky TS, Longnecker R. 2013. A soluble form of Epstein-Barr virus gH/gL inhibits EBV-induced membrane fusion and does not function in fusion. Virology 436: 118-126. http://dx. doi. org/10. 1016/j. virol. 2012. 10. 039.
26. Atanasiu D, Saw WT, Cohen GH, Eisenberg RJ. 2010. Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB. J Virol 84: 12292-12299. http://dx. doi. org/10. 1128/JVI. 01700-10.
27. McShane MP, Mullen MM, Haan KM, Jardetzky TS, Longnecker R. 2003. Mutational analysis of theHLAclass II interaction with Epstein-Barr virus glycoprotein 42. J Virol 77: 7655-7662. http://dx. doi. org/10. 1128/JVI. 77. 13. 7655-7662. 2003.
28. Haan KM, Lee SK, Longnecker R. 2001. Different functional domains in the cytoplasmic tail of glycoprotein B are involved in Epstein-Barr virusinduced membrane fusion. Virology 290: 106-114. http://dx. doi. org/10. 1006/viro. 2001. 1141.
29. Fan Q, Longnecker R. 2010. The Ig-like v-type domain of paired Ig-like type 2 receptor alpha is critical for herpes simplex virus type 1-mediated membrane fusion. J Virol 84: 8664-8672. http://dx. doi. org/10. 1128/JVI. 01039-10.